Clinical Trial Update: Armodafinil (CEP-10953) in Treatment of Excessive Sleepiness Associated With Obstructive Sleep Apnea/Hypopnea Syndrome(OSAHS) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating armodafinil for excessive sleepiness in obstructive sleep apnea/hypopnea syndrome has completed and results were posted in 201…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypopnea
• Obstructive Sleep Apnea

Drugs mentioned

• Armodafinil (armodafinil)

Snippet

Sponsor: Cephalon | Conditions: Obstructive Sleep Apnea, Hypopnea | Phase 3 | Status: COMPLETED | Results posted: 2010-07-29